- Hindi news
- National
- Nasa spacex axiom astronauts mission; Glucose Insulin | Shubhanshu shukla
New DelhiA few moments ago
- Copy link
The Axiom-4 mission has brought a ray of hope for patients with diabetes to travel to space. This is because UAE’s health service provider is doing a research on the behavior of glucose in Burjil Holdings Micrology. The rest of the people, including Indian astronaut Shubhanshu Shukla, will wear glucose monitors 14 days in the orbital lab as a part of the suit ride experiment under the Axiaom-4 mission.
Mohammad Fitayan, CMO of Abu Dhabi’s Burjil Holdings, told PTI that they are just trying to see if there is any change or fluctuation in the level of blood sugar while in space.
The study of the behavior of glucose and insulin in microgravity will help scientists to create wearable techniques for astronauts and patients who are able to do less movement due to diseases like bed or paralysis.
Apart from this, astronaut insulin pens will also be taken along, which will be kept in different temperatures, so that it can be seen what effect the insulin molecules are affected in microgravity.
No sugar patient has gone on space trip yet
The National Aeronautics and Space Administration (NASA) does not allow patients with insulin to go into space. Although there is no official prohibition for patients with not taking insulin, no sugar patient Astronaut has traveled to space yet.
What can this research change
- Astronauts struggling with diabetes may increase the chances of getting the approval of the space mission in the future.
- AI based forecast models will be prepared that will be able to track insulin needs and metabolic changes in real time.
- This research can be helpful in improving diabetes care and tele-health service in remote areas.
- This research will also help in finding the development of new drugs that increase insulin sensitivity and drugs that have as much effect as sitting workouts.